New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma Reports Third Quarter 2022 Financial Results and Clinical Development Updates
-
Lumos Pharma (LUMO) Reports Encouraging Interim Results from Two Phase 2 Trials of Oral LUM-201
-
Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
-
Lumos Pharma Announces Encouraging Interim Results from Two Phase 2 Trials Evaluating Oral LUM-201 for Moderate Pediatric Growth Hormone Deficiency
-
Rise and fall of crypto exchange FTX
-
Rise and fall of crypto exchange FTX
-
Allakos Provides Business Update and Reports Third Quarter 2022 Financial Results
-
Allakos Provides Business Update and Reports Third Quarter 2022 Financial Results
-
Glasswing Ventures Announces Key Additions to Team, Fulfilling its Building Partner Vision
-
Pionyr Immunotherapeutics’ MARCO-targeting Antibody Program, PY265, for Treatment of Solid Tumors Featured at SITC 2022
-
Form SC 13D/A PhaseBio Pharmaceuticals Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
PMV Pharmaceuticals (PMVP) Appoints Carol Gallagher to its Board
-
PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors
-
Courtyard Raises $7M in Seed Funding To Redefine Physical Collectibles Ownership Through NFTs
-
TMRW Sports Adds All-Star Investors
-
Form SC 13D/A Akouos, Inc. Filed by: New Enterprise Associates 16, L.P.
-
Form 4 PhaseBio Pharmaceuticals For: Oct 25 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Timescale Announces Appointment of Jason Montgomery as VP, Sales.
-
Wispr Raises Another $10M to Build a More Natural Way to Interact with Technology
-
Form 4 AVEO PHARMACEUTICALS, For: Oct 19 Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D/A Bright Health Group Inc. Filed by: New Enterprise Associates 15, L.P.
-
Topia Launches Remote Work Solution, Automating Immigration and Tax Compliance for HR Teams
-
Inversago Pharma Announces Appointment of Ed Mathers, BSc and Nanna Lüneborg, PhD, MBA to its Board of Directors
-
Swift Navigation Raises $100 Million Series D Financing Round to Bring Safe and Precise Navigation to Every Vehicle on the Planet
-
Swift Navigation Raises $100 Million Series D Financing Round to Bring Safe and Precise Navigation to Every Vehicle on the Planet
-
Inversago Pharma Raises $95 million CAD in Series C Financing
-
Form SC 13D Allakos Inc. Filed by: New Enterprise Associates 16, L.P.
-
G Squared and Transfix Mutually Agree to Terminate Business Combination Agreement
-
Topia Retains 'Strategic Leader' Status on Fosway 9-Grid™ for Third Straight Year
-
BIO Announces Appointment of Interim CEO
-
MBX Biosciences Advances Phase 1 Clinical Trial of Long-Acting Parathyroid Hormone Peptide Prodrug, MBX 2109
-
Leading Solo VC K2 Global Raises $300 Million to Invest in Start-ups Globally
-
AviadoBio Appoints Graeme Fielder as Chief Operating Officer and Alex Bloom as Chief Technical Officer
-
NEA Welcomes Philip Chopin as Partner
-
SpyGlass Pharma Presents Compelling 3-Month Data from the First-In-Human Trial of Its Innovative Drug Delivery Platform for Chronic Eye Conditions
-
Stride Health Continues Accelerated Growth with Appointment of Lee Hurley as Chief Marketing Officer
-
Cloudflare Announces $1.25 Billion “Workers Launchpad” Funding Program to Help Startups Grow Their Businesses
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
-
Lumos Pharma to Participate in the Cantor Neurology & Psychiatry Conference
-
HEAVY.AI Launches Industry’s First Digital Twin for Telco Network Planning, Building and Operations, Leveraging the NVIDIA Omniverse Platform
-
APX Platform and Revelle Aesthetics, Inc. Enter Unique Strategic Partnership Focused on Growing Demand for Body Rejuvenation
-
Pionyr Immunotherapeutics Doses First Patient in Phase 1b Expansion Study of PY159
-
Allakos (ALLK) Prices 29.88M Share Offering at $5.02/sh
-
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
-
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
-
Lime Connect's Annual Ride to Rebrand Disability hosted in Reston, VA on October 8, 2022
-
SpyGlass Pharma to Unveil Innovative Drug Delivery Platform for Chronic Eye Conditions at Eyecelerator Prior to the American Academy of Ophthalmology Meeting
-
Lefteris Acquisition Corporation Announces Changes in Leadership
-
Arc Launches “Startup Growth Stories” Empowering Founders To Share Their Story

